Atlas Trials

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

Clinical trial NCT07682506 · RECRUITING

Trial details

NCT number
NCT07682506
Sponsor
Minghui Pharmaceutical (Hangzhou) Ltd
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Vitiligo
Start date
2026-08-04
Primary completion
2028-02-23
Enrollment
405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.